KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

LifeMD (LFMD) Long-Term Deferred Tax (2025)

LifeMD (LFMD) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $19.0 million as the latest value for Q4 2025.

For the quarter ending Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $19.0 million, compared with a TTM value of $19.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $19.0 million, changed N/A over the prior year.
Long-Term Deferred Tax was $19.0 million for Q4 2025 at LifeMD.
Across five years, Long-Term Deferred Tax topped out at $19.0 million in Q4 2025 and bottomed at $19.0 million in Q4 2025.